Priveterra Acquisition Corp. (PMGM)
| Market Cap | 292.90M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 29.00M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 5 |
| Last Price | $10.10 |
| Previous Close | $10.00 |
| Change ($) | 0.10 |
| Change (%) | 1.00% |
| Day's Open | 10.02 |
| Day's Range | 9.96 - 10.10 |
| Day's Volume | 84,575 |
| 52-Week Range | 9.95 - 10.51 |
FORT LAUDERDALE, Fla., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Priveterra Acquisition Corp. (Nasdaq: PMGMU) (the “Company”) today announced that it closed its initial public offering of 27,600,000 u...
FORT LAUDERDALE, Fla., Feb. 8, 2021 /PRNewswire/ -- Priveterra Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 24,000,000 units at a price of $1...
Priveterra Acquisition, a blank check company targeting the medical technology sector, filed on Thursday with the SEC to raise up to $200 million in an initial public offering.
Priveterra Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
About PMGM
Priveterra Acquisition is a newly incorporated blank check company incorporated in November 2020 as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to focus on the medical technology sector. Global healthcare expenditures are expected to rise at an approximate compounded annual growth rate of 5% from 2019 to 2023, and represent an approximate 10% share of global gross domestic prod... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Feb 9, 2021 |
| CEO Robert Palmisano | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol PMGM |